Newron Pharmaceuticals S.p.A. (“Newron”), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area, announced today that the EU Committee for Medicinal Pro-ducts for Human Use (CHMP) recommended that the European Commission approve the use of Xadago™ (safinamide) as add-on to L-dopa alone or in combination with dopamine agonists, entacapone, amantadine, and/or anticholinergics, for the treatment of patients with mid-late stage Parkinson’s disease experiencing motor fluctuations despite being stabilized on ‘Standard of Care’.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7406951-chmp-xadago-parkinsons/
Not-for-profit pension provider NEST (National Employment Savings Trust) is urging consumers to keep their passions alive into later life as one of their New Year resolutions. Its research suggests that over 65s often have better social lives than any other age group except the under 25s.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64179-new-year-resolution-not-give-up-nest
Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the COMPACT study, a pivotal Phase III study evaluating the safety and efficacy of CSL830 (a novel, investigational, self-administered, subcutaneous C1-Esterase Inhibitor [C1-INH] Human replacement therapy) for the prevention of HAE attacks. The study met its primary efficacy endpoint, significantly reducing the time-normalized number of HAE attacks. In addition, the study met its secondary endpoints, including the responder rate (patients who had at least a 50% reduction in their attack rate) and the number of rescue medication uses. If approved by the FDA, CSL830 would be the first and only subcutaneous preventative therapy for HAE.
To view the multimedia release go to:
https://www.multivu.com/players/English/8056151-csl-behring-subcutaneous-c1-esterase-inhibitor-hae-patients/
Today Safe Kids Worldwide released a new research report that found kids are getting into medicine at an alarming rate. Every minute of every day, a poison control center receives a call about a potential medicine poisoning for a child age five and under. And 67,000 times each year, or every eight minutes, a young child goes to the emergency room for medicine poisoning. This is a 30 percent increase over the past ten years.
In its report entitled An In-Depth Look at Keeping Young Children Safe Around Medicine, Safe Kids examines data from the U.S. Consumer Product Safety Commission, information from poison control centers and findings from several focus groups among moms. The report reviews what is happening in households that leads to these disturbing numbers and offers parents simple things they can do to protect their children.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60845-safe-kids-worldwide-keeping-young-children-safe-around-medicine
China's leading automobile manufacturer GAC Motor has released the first concept car EnLight on November 18 at the 14th China (Guangzhou) International Automobile Exhibition, marking a new milestone in the company’s continuous path of innovation.
EnLight is an unprecedented smart electric supercar that applies the latest cutting-edge technologies, most futuristic design concepts and natural driving experience. The slim bodied supercar with butterfly wing doors has both the autonomous and manual driving modes while achieving four-wheel independent drive with the in-wheel motors.
“EnLight is a forward-thinking concept car representing the highest level of GAC Motor’s independent research and development as well as our unparalleled technological capabilities, which will also provide GAC Motor strong confidence and support to seek advanced development in the direction of reaching the top of the auto industry through innovation and creativity,” said Zeng Qinghong, president of GAC Motor.
To view the multimedia release go to:
http://www.multivu.com/players/English/7994651-gac-motor-smart-electric-concept-supercar/
TransCelerate BioPharma Inc., a non-profit organization dedicated to improving the health of people around the world by simplifying and accelerating research and development of innovative new therapies, has unveiled a new global campaign designed to help increase awareness of the growing need for clinical trial participants. The campaign, called “One Person Closer,” focuses on inspiring healthcare professionals (HCPs) to consider clinical research as a possibility for their patients, incorporate the topic into their daily practices, and have meaningful conversations with patients about opportunities to participate in clinical trials.
One Person Closer is designed to put a human face on research and development by sharing the personal stories of researchers, HCPs and patients who have contributed to clinical research and the development of medical breakthroughs. The photojournalist campaign aims to show doctors, nurses and other HCPs that they can help facilitate research that advances science and that may benefit their patients.
To view the multimedia release go to:
https://www.multivu.com/players/English/8268751-transcelerate-biopharma-one-person-closer/
Volvo Cars’ ongoing research into autonomous driving has confirmed what we all know - that the daily commute is taking the joy out of driving. It is during the commute and on long-haul motorway trips that people are most willing to delegate the act of driving to their car.
With this in mind Volvo has developed Concept 26, named to reflect the average daily commute to work of 26 minutes – time that could be spent doing something more meaningful than sitting in stop-go traffic. Volvo has set out to bring choice and freedom back to the driver; to enjoy the driving experience when they want to, or to delegate driving to the car when they want to do something else.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7694951-volvo-cars-unveils-concept-26/
Losing weight and being healthier are at the top of everyone’s New Year’s resolutions. But, despite the best intentions, work, kids, and social events often push lifestyle changes to the bottom of the list. While many are familiar with type 2 diabetes, fewer are aware of prediabetes, a serious health condition that affects 86 million Americans (more than 1 in 3) and often leads to type 2 diabetes. People with prediabetes have higher than normal blood glucose (sugar) levels, but not high enough yet to be diagnosed with type 2 diabetes.
To raise awareness and help people with prediabetes know where they stand and how to prevent type 2 diabetes, the American Diabetes Association (ADA), the American Medical Association (AMA), and the Centers for Disease Control and Prevention (CDC) have partnered with the Ad Council to launch the first national public service advertising (PSA) campaign about prediabetes. The PSA campaign, featuring first-of-its-kind communications techniques, was developed pro bono by Ogilvy & Mather New York for the Ad Council.
Nearly 90 percent of people with prediabetes don’t know they have it and aren’t aware of the long-term risks to their health, including type 2 diabetes, heart attack, and stroke. Current trends suggest that, if not treated, 15 to 30 percent of people with prediabetes will develop type 2 diabetes within five years. The good news is that prediabetes often can be reversed through weight loss, diet changes and increased physical activity. Diagnosis is key: research shows that once people are aware of their condition, they are much more likely to make the necessary lifestyle changes.
To view the multimedia release go to:
http://www.multivu.com/players/English/7731551-ad-council-prediabetes-psa/
As breakthroughs in cancer treatments are occurring at an ever increasing rate, The Leukemia & Lymphoma Society (LLS) is shining a spotlight on the women in science who are helping to lead these advances.
Through its significant investment in cancer research – more than $1.2 billion since its founding nearly 70 years ago – LLS is committed to funding and recognizing female scientists, physicians, social workers and nurses, and encouraging young women to participate in STEM (science, technology, engineering and math) education and pursue careers in the sciences.
To view the multimedia release go to:
https://www.multivu.com/players/English/8128552-lls-women-in-science/
Online Registration Guidline
ACRI is specialized in providing Clinical Research Courses like Pg Diploma in clinical CDM and SAS course with guarantee internship in leading CRO’S & 100% Placement.
Reach us at:
Avigna Clinical Research Institute:-
No.33,3rd Floor,15th Cross,
2nd Phase,J.P.Nagar,100ft Ring Road,
Bangalore-560078
080-26588910 / 91-9741600499
http://www.acriindia.com
info@acriindia.com
Speed Drawing Animation as a method for interactive learning for children. Is it possible? Sure it is!
Research study said that children tend to learn & develop logics through their visual memory. 25SDA creates a funny interactive Speed Drawing Animation on how to save energy.
Now, knowledge can be this fun!
*Note: This speed drawing animation was categorized as UNIVERSAL Package on 25SDA Package Deals! Discover the most fits Speed Drawing Animation for your needs on http://25sda.com/
Created by 25SDA
Clearwater - FL
Hotline 1-800-826-8148
Visit our page at http://25sda.com/
Facebook Page https://www.facebook.com/25sda
Follow us on Twitter @25SDA
